Q4 2015 Holdings
Filed 2016-02-16 | 57 holdings | $52.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $41.5M | 2,251,020 | 78.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $9.8M | 122,400 | 18.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $99.7K | 10,280,620 | 0.2% |
| Medivation Inc | COM | 58501N101 | $77.3K | 1,599,393 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $76.2K | 1,537,570 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $75.3K | 17,850,650 | 0.1% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $65.8K | 1,223,717 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $62.9K | 1,795,936 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $61.6K | 1,372,492 | 0.1% |
| Teva Pharmaceutical Inds LTD(TEVA) | ADR | 881624209 | $61.6K | 938,139 | 0.1% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $55.9K | 958,374 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $49.3K | 958,155 | 0.1% |
| Wellcare Health Plans Inc | COM | 94946T106 | $44.0K | 562,873 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $42.6K | 3,671,344 | 0.1% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $41.0K | 16,610 | 0.1% |
| Pfizer IncCall | CALL | 717081903 | $40.7K | 1,260,400 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $40.5K | 1,534,962 | 0.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $38.8K | 357,912 | 0.1% |
| Diplomat Pharmacy Inc(DPLOEUR) | COM | 25456K101 | $38.2K | 1,115,902 | 0.1% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $28.0K | 415,198 | 0.1% |
| Neuroderm LTD | ORD SHS | M74231107 | $27.1K | 1,589,261 | 0.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $26.9K | 408,000 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $25.3K | 1,391,813 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $22.0K | 187,034 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $21.5K | 68,758 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $20.8K | 1,868,159 | 0.0% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $20.2K | 709,426 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $20.0K | 1,357,692 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $18.3K | 1,213,627 | 0.0% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $14.4K | 738,356 | 0.0% |
| Health NET Inc | COM | 42222G108 | $12.4K | 181,029 | 0.0% |
| Endologix Inc | COM | 29266S106 | $10.0K | 1,007,177 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $9.9K | 860,288 | 0.0% |
| Trivascular Technologies Inc | COM | 89685A102 | $9.7K | 1,462,762 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $8.0K | 2,371,001 | 0.0% |
| Press Ganey Hldgs Inc | COM | 74113L102 | $7.6K | 239,616 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $7.3K | 276,687 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $7.1K | 218,718 | 0.0% |
| Durect Corp(DRRXEUR) | COM | 266605104 | $5.8K | 2,628,416 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $5.4K | 660,129 | 0.0% |
| Oncothyreon Inc | COM | 682324108 | $5.2K | 2,331,300 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $4.8K | 557,193 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $4.0K | 123,800 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $3.7K | $4,000,000 | 0.0% |
| Eleven Biotherapeutics Inc | COM | 286221106 | $2.6K | 875,857 | 0.0% |
| Conformis Inc(CFMS) | COM | 20717E101 | $2.2K | 125,709 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $1.2K | 10,055 | 0.0% |
| Ishares TR(IHF) | US HLTHCR PR ETF | 464288828 | $562 | 4,520 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $512 | 63,189 | 0.0% |
| Pronai Therapeutics Inc | COM | 74346L101 | $373 | 24,787 | 0.0% |